India Vaccine Export Boost 2025: What Pharma Firms Achieve
July 1, 2025
The India Vaccine Export Boost 2025 is a proud testament to the country’s global leadership in affordable and high-quality vaccine manufacturing. Post-pandemic recovery has strengthened India’s pharmaceutical exports, and vaccines are now one of the top contributors. In 2025, Indian ... Read more
Pharma Pricing Policy Amendment 2025: NPPA Price Caps Explained
July 1, 2025
The Pharma Pricing Policy Amendment 2025 has officially brought a new wave of price control and accessibility in India’s healthcare system. With updated price capping mechanisms and broader coverage of essential drugs, the National Pharmaceutical Pricing Authority (NPPA) has taken ... Read more
Over-the-Counter Drug Regulation India 2025 – CDSCO Rule Changes
June 30, 2025
The Central Drugs Standard Control Organization (CDSCO) has officially implemented the Over-the-Counter Drug Regulation India 2025, introducing a revised framework for the sale, labeling, and promotion of non-prescription medicines. These changes aim to strengthen consumer safety, enhance product quality, and ... Read more
PLI Scheme for Bulk Drug Manufacturing 2025 – New Subsidy Guidelines
June 30, 2025
The Government of India has updated the Bulk Drug Production Linked Incentive Scheme 2025, providing revised subsidies and guidelines for the manufacturing of critical Active Pharmaceutical Ingredients (APIs) within the country. This initiative supports the “Atmanirbhar Bharat” mission by reducing ... Read more
NLEM 2025 – New Essential Medicines List Released by Govt
June 30, 2025
The Ministry of Health and Family Welfare has officially released the National List of Essential Medicines Update 2025, adding several new life-saving drugs to the NLEM. This update marks a significant move toward accessible and affordable healthcare in India, ensuring ... Read more
Jan Aushadhi Expansion 2025 – 5,000 New Stores to Open Across India
June 30, 2025
The Indian government has officially launched the Jan Aushadhi Store Expansion Plan 2025, announcing the opening of over 5,000 new Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) across the country by March 2025. This major expansion aims to improve affordable healthcare ... Read more
CDSCO New Drug Approval Rules 2025 – Faster Clearance Timeline
June 28, 2025
The CDSCO Rules for New Drugs 2025 have officially come into effect, marking a major reform in India’s pharmaceutical regulatory framework. The Central Drugs Standard Control Organisation (CDSCO) has overhauled its drug approval process to reduce delays, promote innovation, and ... Read more
New Pharma Manufacturing Hubs 2025 – State-Wise Cluster Expansion
June 28, 2025
The Pharma Manufacturing Hubs 2025 initiative is transforming India’s pharmaceutical production landscape with state-of-the-art industrial clusters across the country. Under the Atmanirbhar Bharat and Pharma Vision 2047 programmes, the Government of India has announced the operational rollout of several new ... Read more
India’s Bulk Drug Import 2025 – Top Countries & Industry Impact
June 28, 2025
The Indian Pharma Bulk Drug Import 2025 landscape reveals some critical trends in sourcing, cost dynamics, and dependency on global suppliers. Despite India being a global leader in generic drug manufacturing, a significant portion of Active Pharmaceutical Ingredients (APIs) and ... Read more
Pharma Innovation Fund India 2025 – ₹1500 Cr Scheme Details & Benefits
June 28, 2025
The Government of India has officially launched the Pharma Innovation Fund India 2025, allocating ₹1500 crore to fuel pharmaceutical research and development across the country. This strategic initiative is aimed at boosting India’s self-reliance in drug discovery, biotechnology, and formulation ... Read more